Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer

The initial surgical management of asymptomatic patients with unresectable stage IV colorectal cancer (CRC) is still controversy. The aim of this study was to compare the incidence of major intestinal complications in asymptomatic patients who received palliative treatment for unresectable stage IV CRC, according to the type of treatment.

[1]  T. Ruers,et al.  Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  B. Mehrotra,et al.  Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[3]  M. Orditura,et al.  First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. , 2008, Archives of surgery.

[4]  A. Neugut,et al.  Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review , 2008, International Journal of Colorectal Disease.

[5]  L. Veronesi,et al.  Palliative Resection of Colorectal Cancer: Does It Prolong Survival? , 2007, Annals of Surgical Oncology.

[6]  Y. Cho,et al.  The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient’s status , 2007, International Journal of Colorectal Disease.

[7]  A. Muratore,et al.  Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy? , 2007, Annals of Surgical Oncology.

[8]  H. Schlitt,et al.  Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. , 2006, World journal of gastroenterology.

[9]  W. Law,et al.  Outcomes of resection of stage IV rectal cancer with mesorectal excision , 2006, Journal of surgical oncology.

[10]  B. Nordlinger,et al.  Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases , 2005, The British journal of surgery.

[11]  R. Single,et al.  Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000 , 2005, Annals of Surgical Oncology.

[12]  R. Koch,et al.  Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: A multivariate analysis , 2005, Journal of surgical oncology.

[13]  R. Leicester,et al.  Eight Years Experience of High-Powered Endoscopic Diode Laser Therapy for Palliation of Colorectal Carcinoma , 2005, Diseases of the colon and rectum.

[14]  L. Temple,et al.  Use of surgery among elderly patients with stage IV colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Scotté,et al.  Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? , 2004, Gastroenterologie clinique et biologique.

[16]  S. H. Cheng,et al.  How aggressive should we be in patients with stage iv colorectal cancer? , 2003, Diseases of the colon and rectum.

[17]  J. Guillem,et al.  Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. , 2003, Journal of the American College of Surgeons.

[18]  A. Norman,et al.  Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases , 2003, Gut.

[19]  R. Beart,et al.  Placement of self-expanding metal stents for acute malignant large-bowel obstruction: A collective review , 2002, Annals of Surgical Oncology.

[20]  N. Munshi,et al.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.

[21]  P. Guillou,et al.  Non‐operative management of the primary tumour in patients with incurable stage IV colorectal cancer , 2001, The British journal of surgery.

[22]  M. Posner,et al.  Initial presentation with stage IV colorectal cancer: how aggressive should we be? , 2000, Archives of surgery.

[23]  J. Church,et al.  Operation in patients with incurable colon cancer—Is it worthwhile? , 1997, Diseases of the colon and rectum.

[24]  M. Buyse,et al.  The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. , 1995, The New England journal of medicine.

[25]  L. Påhlman,et al.  Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer , 1994, Cancer.

[26]  S. Steinberg,et al.  Prognostic indicators of colon tumors. The gastrointestinal tumor study group experience , 1986, Cancer.

[27]  G. Bodey,et al.  Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Leach,et al.  Nonoperative Management of Primary Colorectal Cancer in Patients With Stage IV Disease , 1999, Annals of Surgical Oncology.